XTACY Therapeutics Provides Bi-Weekly MCTO Status Update
Vancouver, February, 13, 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (the “Company”) is providing a bi-weekly default status update in accordance
GLOBAL WELLNESS STRATEGIES
Vancouver, February, 13, 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (the “Company”) is providing a bi-weekly default status update in accordance
Vancouver, February 7th 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“Xtacy” or the “Company”) is pleased to announce an LOI with
Vancouver January 30, 2024 – XTACY THERAPEUTICS CORP. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“Xtacy Therapeutics” or the “Company”) announces today a Management Cease
Vancouver December 5th, 2023 – Xtacy Therapeutics Corp. (CSE: XTCY) (Frankfurt: O3X4) (OTCQB: XTCYF) (“the Company) announces expansion of its MDMA research platform to help
NON-REGISTERED (BENEFICIAL) SECURITYHOLDERS We are sending to you the enclosed proxy-related materials that relate to a meeting of the holders of the series or class
NOTICE IS HEREBY GIVEN that the Annual General meeting (the “Meeting”) of GLOBAL WELLNESS STRATEGIES INC. (the “Company”) will be held at Suite 1100 –